Ivermectin for Cancer: The Latest Breakthroughs You Need to Know New research from UCLA and Cedars-Sinai shows ivermectin may help in treating solid organ cancers. Once dismissed, now it’s entering serious trials—and patients are already adding it to chemo and radiation regimens. 👉 Fund the independent research the system won’t. 👉 Donate today: mcculloughfnd.org Credit: LIVE FROM STUDIO 6B SHOW @lfs6b #MedicalFreedom | McCullough Foundation

Ivermectin isn’t just an anti-parasitic medication. It’s being explored for its anti-cancer potential, and here’s what you need to know: 1. Delivery Methods • Oral: Most common, offering systemic absorption. • Transdermal: Applied to the skin for localized effects. • Rectal: Unique pharmacokinetics for specific conditions. • Nebulized: Targets lungs and nasopharynx with low systemic availability. • Intranasal: Safe at 1 mg per nostril for localized action. • Intraperitoneal (IP): In rats, low do

Ivermectin isn’t just an anti-parasitic medication. It’s being explored for its anti-cancer potential, and here’s what you need to know: 1. Delivery Methods • Oral: Most common, offering systemic absorption. • Transdermal: Applied to the skin for localized effects. • Rectal: Unique pharmacokinetics for specific conditions. • Nebulized: Targets lungs and nasopharynx with low systemic availability. • Intranasal: Safe at 1 mg per nostril for localized action. • Intraperitoneal (IP): In rats, low do